Am J Hematol
- COSTA BA, Costa TA, Saravia SD, Felix N, et al
Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide
and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic
review and meta-analysis.
Am J Hematol. 2024 Mar 15. doi: 10.1002/ajh.27288.
Am J Respir Crit Care Med
- LILEY J, Newnham M, Bleda M, Bunclark K, et al
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and
Pulmonary Embolism.
Am J Respir Crit Care Med. 2024 Mar 12. doi: 10.1164/rccm.202307-1236.
Chest
- FRAT JP, Ciurzynski M
Intermediate-Risk Acute Pulmonary Embolism: Simply Oxygen?
Chest. 2024;165:484-485.
Clin Nucl Med
- SUNG C, Han S, Yoon S, Han SA, et al
Diagnostic Performance of Perfusion-Only SPECT/CT for Chronic Thromboembolic
Pulmonary Hypertension in Comparison With Ventilation-Perfusion Planar, SPECT,
and SPECT/CT Imaging.
Clin Nucl Med. 2024 Mar 11. doi: 10.1097/RLU.0000000000005142.
Heart
- MERCADE-BESORA N, Li X, Kolde R, Trinh NT, et al
The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and
cardiovascular complications.
Heart. 2024 Mar 12:heartjnl-2023-323483. doi: 10.1136/heartjnl-2023-323483.
Thromb Res
- OGIHARA Y, Yamashita Y, Morimoto T, Chatani R, et al
Fragility and long-term clinical outcomes in patients with venous thromboembolism
receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2.
Thromb Res. 2024;236:191-200.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016